Bridge Biotec

Nanotech delivered peptides to safely and effectively treat serious inflammatory diseases

OWNER

Mike Davis (See Profile)


Sector

Nanotechnology

Stage

In vitro, proof of concept

Country

UK

Has been cash generative and operated from non-dilutive income from clinical partners since day one

Focussing on a $4.1bn private patient market that has grown 64% since 2014

PATENTED TECHNOLOGIES TARGETING $9.2B INFLAMMATORY BOWEL DISEASE AND $104B INFLAMMATORY MARKET

OVER 20 YEARS OF DRUG DEVELOPMENT EXPERIENCE FROM PATENTS TO MARKET APPROVAL

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 9 May 2018.

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar